Olivier Aubert,Daniel Yoo,Dina Zielinski,Emanuele Cozzi,Massimo Cardillo,Michael Dürr,Beatriz Domínguez-Gil,Elisabeth Coll,Margarida Ivo Da Silva,Ville Sallinen,Karl Lemström,Karsten Midtvedt,Camilo Ulloa,Franz Immer,Annemarie Weissenbacher,Natalie Vallant,Nikolina Basic-Jukic,Kazunari Tanabe,Georgios Papatheodoridis,Georgia Menoudakou,Martin Torres,Carlos Soratti,Daniela Hansen Krogh,Carmen Lefaucheur,Gustavo Ferreira,Helio Tedesco Silva Jr,David Hartell,John Forsythe,Lisa Mumford,Peter P Reese,François Kerbaul,Christian Jacquelinet,Serge Vogelaar,Vassilios Papalois,Alexandre Loupy

Abstract:Background: Preliminary data suggest that COVID-19 has reduced access to solid organ transplantation. However, the global consequences of the COVID-19 pandemic on transplantation rates and the effect on waitlisted patients have not been reported. We aimed to assess the effect of the COVID-19 pandemic on transplantation and investigate if the pandemic was associated with heterogeneous adaptation in terms of organ transplantation, with ensuing consequences for waitlisted patients. Methods: In this population-based, observational, before-and-after study, we collected and validated nationwide cohorts of consecutive kidney, liver, lung, and heart transplants from 22 countries. Data were collected from Jan 1 to Dec 31, 2020, along with data from the same period in 2019. The analysis was done from the onset of the 100th cumulative COVID-19 case through to Dec 31, 2020. We assessed the effect of the pandemic on the worldwide organ transplantation rate and the disparity in transplant numbers within each country. We estimated the number of waitlisted patient life-years lost due to the negative effects of the pandemic. The study is registered with ClinicalTrials.gov, NCT04416256. Findings: Transplant activity in all countries studied showed an overall decrease during the pandemic. Kidney transplantation was the most affected, followed by lung, liver, and heart. We identified three organ transplant rate patterns, as follows: countries with a sharp decrease in transplantation rate with a low COVID-19-related death rate; countries with a moderate decrease in transplantation rate with a moderate COVID-19-related death rate; and countries with a slight decrease in transplantation rate despite a high COVID-19-related death rate. Temporal trends revealed a marked worldwide reduction in transplant activity during the first 3 months of the pandemic, with losses stabilising after June, 2020, but decreasing again from October to December, 2020. The overall reduction in transplants during the observation time period translated to 48 239 waitlisted patient life-years lost. Interpretation: We quantified the impact of the COVID-19 pandemic on worldwide organ transplantation activity and revealed heterogeneous adaptation in terms of organ transplantation, both at national levels and within countries, with detrimental consequences for waitlisted patients. Understanding how different countries and health-care systems responded to COVID-19-related challenges could facilitate improved pandemic preparedness, notably, how to safely maintain transplant programmes, both with immediate and non-immediate life-saving potential, to prevent loss of patient life-years. Funding: French national research agency (INSERM) ATIP Avenir and Fondation Bettencourt Schueller.

Early Impact of COVID-19 on Solid Organ Transplantation in the United States

Early impact of COVID‐19 on transplant center practices and policies in the United States

LUNG TRANSPLANTATION DURING THE OUTBREAK OF CORONAVIRUS DISEASE 2019: EARLY EXPERIENCE FROM CHINA

Coronavirus Disease 2019 in Solid Organ Transplant: A Multicenter Cohort Study

SARS-CoV-2 Infection in Transplant-Related Biology: Where Do We Stand?

Lung transplantation during the outbreak of Coronavirus Disease 2019 in China

Impact of solid organ transplant status on outcomes of hospitalized patients with COVID‐19 infection

Poor Compliance Causes Acute Rejection in Kidney Transplant Recipients During COVID-19 Pandemic: 2 Cases Report

Trinational Study Exploring the Early Impact of the COVID-19 Pandemic on Organ Donation and Liver Transplantation at National and Unit Levels

Evolving Impact of COVID‐19 on Transplant Center Practices and Policies in the United States

COVID-19 pandemic and worldwide organ transplantation: a population-based study

The impact of COVID‐19 on kidney transplantation and the kidney transplant recipient – One year into the pandemic

Mortality among solid organ waitlist candidates during COVID-19 in the United States

[Impact of the COVID-19 pandemic on hepato-pancreato-biliary surgery and organ transplantation]

Challenges Faced by Solid Organ Transplant Recipients During the COVID-19 Pandemic in France: Historical Insights and Key Takeaways

Chronological and Geographical Variations in the Incidence and Acceptance of COVID-19-Positive Donors and Outcomes Among Abdominal Transplant Patients

The association between severe or death COVID-19 and solid organ transplantation: A systematic review and meta-analysis

Solid organ transplantation programs facing lack of empiric evidence in the COVID-19 pandemic: A By-proxy Society Recommendation Consensus approach

The burden of COVID-19 mortality among solid organ transplant recipients in the United States

Longitudinal outcomes of COVID-19 in solid organ transplant recipients from 2020 to 2023

Prospective Clinical, Virologic, and Immunologic Assessment of COVID-19 in Transplant Recipients